Clinical Trial

A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Name: A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. — clinical trial record (NCT07414316)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

A Single-Center, Open-Label Clinical Study to Evaluate the Safety, Preliminary Efficacy of GK01 Cell Injection in Subjects with Advanced Solid Tumors Refractory or Intolerant to Standard Therapy

Trial Details

NCT Number	NCT07414316
Lead Sponsor	Beijing Geekgene Technology Co., LTD Collaborators: The First Affiliated Hospital of Nanchang University
Conditions	Advanced Solid Tumors
Enrollment	10 participants
Start Date	2026-02-13
Primary Completion	2027-02-12 (estimated)
Study Completion	2028-02-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-17